The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Of 'Use' and Labels: Recent Appellate Decisions in Hatch-Waxman Litigation" on May 3, 2012 beginning at 2:00 pm (ET). A panel consisting of James Hurst of Winston & Strawn, LLP; Andrea Kamage of Johnson & Johnson; and Christina Markus of King & Spalding will review the Supreme Court's decision in Caraco v. Novo Nordisk and the Federal Circuit's decisions in AstraZeneca v. Apotex and Bayer v. Lupin, and discuss how these decisions will influence the future of patent prosecution and litigation.
The registration fee for the webinar is $120 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- DNA Genotek Inc. v. Spectrum Solutions LLC (Fed. Cir. 2025)
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- Five Years Ago Today . . .
- President Nominates John Squires to be Next USPTO Director
- Immunogen, Inc. v. Stewart (Fed. Cir. 2025)
- Judge Newman Files Reply Brief in Newman v. Moore
- One of the Early Appeal Decisions in Quantum Computing Represents a Positive Datapoint
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
- Aurobindo v. Merck Sharp and Dohme -- Oral Argument
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« AALS 2012 MidYear Meeting | Main | Conference & CLE Calendar »
April 29, 2012
The comments to this entry are closed.
March 2025
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (278)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (107)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (27)
- District Court (223)
- Double Patenting (42)
- Enablement (52)
- Federal Circuit (1033)
- Food and Drug Administration (112)
- Hatch-Waxman (96)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (92)
- Injunction (39)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (169)
- News from Abroad (102)
- Novelty (74)
- Obviousness (236)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (833)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (370)
- Patentable Subject Matter (645)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (8)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (90)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments